Anti-IL-8 Autoantibodies in Alveolar Fluid from Patients with the Adult Respiratory Distress Syndrome

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2699-2706

  Kurdowska, Anna ^a   Miller, Edmund J ^a,e   Noble, James M ^a   Baughman, Robert P ^c   Matthay, Michael A ^d   Brelsford, William G ^b   Cohen, Allen B ^a,b  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b Health Science Center   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Pulmonary Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 8;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; GEL CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG LAVAGE; METHODOLOGY; SYNOVIAL FLUID;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; BLOOD CHEMICAL ANALYSIS; BRONCHOALVEOLAR LAVAGE FLUID; CHROMATOGRAPHY, GEL; HUMANS; INTERLEUKIN-8; RESPIRATORY DISTRESS SYNDROME, ADULT; SYNOVIAL FLUID;

EID: 0030587075     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Miller, E. J., A. B. Cohen, S. Nagao, D. Griffith, R. J. Maunder, T. R. Martin, J. P. Weiner-Kronish, M. Sticherling, E. Christophers, and M. A. Matthay. 1992. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146:427.
2. Holter, J. F., J. E. Weiland, E. R. Pacht, J. E. Gadek, and W. B. Davis. 1986. Protein permeability in the adult respiratory distress syndrome: loss of size selectivity of the alveolar epithelium. J. Clin. Invest. 78:1513.
3. 4 in the human lung: recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J. Clin. Invest. 84:1609.
4. Clark, J. G., J. A. Milberg, K. P. Steinberg, and L. D. Hudson. 1994. Type III procollagen peptide in adult respiratory distress syndrome: association of increased peptide levels in bronchoalveolar lavage with increased risk for death. Ann. Intern. Med. 122:17.
5. Svenson, M., L. K. Poulsen, A. Fomsgaard, and K. Bendtzen. 1989. IgG autoantibodies against IL-1α in sera of normal individuals. Scand. J. Immunol. 29: 489.
6. Monti, E., A. Pozzi, L. Tiberio, D. Morelli, A. Caruso, M. L. Villa, and A. Balsari. 1993. Purification of interleukin-2 antibodies from healthy individuals. Immunol. Lett. 36:261.
7. Fomsgaard, A., M. Svenson, and K. Bendtzen. 1989. Auto-antibodies to tumor necrosis factor α in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. Scand. J. Immunol. 30:219.
8. Caruso, A., C. Bonfanti, D. Colombrita, M. de Francesco, C. de Rango, I. Foresti, F. Gargiulo, R. Gonzales, G. Gribaudo, S. Landolfo, N. Manca, G. Manni, F. Pirali, P. Pollara, G. Ravizzola, G. Scura, L. Terlenghi, E. Viani, and A. Turano. 1990. Natural antibodies to IFN-γ in man and their increase during viral infection. J. Immunol. 144:685.
9. Takemura, H., H. Suzuki, K. Yoshizaki, A. Ogata, T. Yuhara, T. Akama, K. Yamane, and H. Kasiwagi. 1992. Anti-interleukin-6 autoantibodies in rheumatic diseases: increased frequency in the sera of patients with systemic sclerosis. Arthritis Rheum. 35:940.
10. Sylvester, I., A. F. Suffredini, A. J. Boujoukos, G. D. Martich, R. L. Danner, T. Yoshimura, and E. J. Leonard. 1993. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum: effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. J. Immunol. 151:3292.
11. Peichl, P., M. Ceska, H. Broell, F. Effenberger, and I. J. D. Lindley. Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Ann. Rheum. Dis. 51:19.
12. Sylvester, I., T. Yoshimura, M. Sticherling, J.-M. Shroder, M. Ceska, P. Peichl, and E. J. Leonard. 1992. Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J. Clin. Invest. 90:471.
13. Crabtree, J. E., P. Peichl, J. I. Wyatt, U. Stachl, and I. J. D. Lindley. 1993. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand. J. Immunol. 37:65.
14. Miller, E. J., A. B. Cohen, F. K. Carr, S. Hayashi, C. Y. Chiu, C. T. Lee-Ng, and G. Mullenbach. 1995. High yields of interleukin-8 produced by a synthetic gene expressed in Escherichia coli and purified with a single antibody affinity column. Protein Express. Purific. 6:357.
15. Yoshimura, T., E. A. Robinson, E. Appella, K. Matsushima, S. D. Showalter, A. Skeel, and E. J. Leonard. 1989. Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the aminoterminal sequence. Mol. Immunol. 26:87.
16. Martin, T. R., B. P. Pistorese, L. D. Hudson, and R. J. Maunder. 1991. Function of lung and blood neutrophils in patients with the adult respiratory distress syndrome: implications for the pathogenesis of lung infections. Am. Rev. Respir. Dis. 144:254.
17. Matthay, M. A., and J. P. Wierner-Kronish. 1990. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am. Rev. Respir. Dis. 142:1250.
18. Miller, E. J., and W. G. Brelsford. 1993. Interleukin 8: the major neutrophil chemotaxin in a case of pseudogout. J. Rheumatol. 20:1250.
19. Ko, Y., N. Mukaida, A. Panyutich, N. N. Voitenok, K. Matsushima, T. Kawai, and T. Kasahara. 1992. A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J. Immunol. Methods 149:227.
20. Hunter, W. M., and F. C. Greenwood. 1961. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495.
21. Liddell, J. E., and A. Cryer. 1991. Characterization, purification and labelling. In A Practical Guide to Monoclonal Antibodies. Wiley-Liss, Chichester, U.K., p. 110.
22. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 × g. Scand. J. Clin. Lab. Invest. 21:77.
23. Grob, P. M., E. David, T. C. Warren, R. P. DeLeon, P. R. Farina, and C. A. Homon. 1990. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. J. Biol. Chem. 265:8311.
24. Zigmond, S., and J. Hirsch. 1973. Leukocyte locomotion and chemotaxis. J. Exp. Med. 137:387.
25. Snyderman, R., and M. C. Pyke. 1981. Chemotaxis of mononuclear cells. In In-Vitro Methods in Cell Mediated and Tumor Immunity. R. Bloom and J. R. David, eds. Academic Press, New York, p. 651.
26. Saurat, J.-H., J. Schifferli, G. Steiger, J.-M. Dayer, and L. Didierjean. 1991. Anti-interleukin-1 α autoantibodies in humans: characterization, isotope distribution, and receptor-binding inhibition-higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J. Allergy Clin. Immunol. 88:244.
27. Bendtzen, K., M. Svenson, V. Jønsson, and E. Hippe. 1990. Autoantibodies to cytokines-friends or foes? Immunol. Today 11:167.
28. Oppenheim, J. J., C. O. C. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of me novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617.
29. Young, W. J., P. Cohen, and R. A. Eisenberg. 1988. Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA, SS-B, and IgG rheumatoid factor. Mongr. Allergy 23:41.
30. Ferrante, A., L. J. Beard, and R. G. Feldman. 1990. IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr. Infect. Dis. J. 9:516.
31. Bice, D. E. 1993. Pulmonary responses to antigen. Chest 103:95S.
32. Avrameas, S. 1991. Natural autoantibodies: from 'Horror Autotoxicus' to 'Gnothi Seauton.' Immunol. Today 12:154.
33. Suzuki, H., J. Kamimura, T. Ayabe, and H. Kashiwagi. 1990. Demonstration of neutralizing autoantibodies against IL-1α in sera from patients with rheumatoid arthritis. J. Immunol. 145:2140.
34. Chang, S.-W. 1992. Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils. Clin. Res. 40:528.